Compare ADMA Biologics Inc (ADMA) vs BlackRock TCP Capital Corp (TCPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs BlackRock TCP Capital Corp — how do they compare? ADMA Biologics Inc trades at $9.87 (market cap $2.22B), while BlackRock TCP Capital Corp trades at $3.88 (market cap $327.64M). The key difference: ADMA Biologics Inc is far larger — about 6.8× BlackRock TCP Capital Corp's market cap, and BlackRock TCP Capital Corp pays a 19.46% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | TCPC | |
|---|---|---|
Market Cap | $2.22B | $327.64M |
Sector | Health | Financials |
52-Week High | $20.38 | $7.26 |
52-Week Low | $7.60 | $3.13 |
Enterprise Value | $2.29B | — |
Dividend Yield | — | 19.46% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About BlackRock TCP Capital Corp
BlackRock TCP Capital Corp is a finance company specializing in middle-market lending. It aims for high returns through income and capital appreciation while prioritizing principal protection. The company invests in debt securities and earns revenue from interest payments, fees, and some equity appreciation.
Read more on TCPC →
